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declined 2.3-fold, suggesting that metabolic suppression as well
as cell losses contributed to the inhibitory effect of rotenone on
overall biosynthetic activity. Although there was no change in pro-
teoglycan content attributable to rotenone treatment, it is possible
that proteoglycan depletion may have been detectable with longer
culture times. These ﬁndings support the hypothesis that chronic
suppression of mitochondrial activity inhibits protein synthesis.
However, it is still unclear if these effects lead to cartilage matrix
instability.
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INTRODUCING A NEW EX VIVO MODEL FOR
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SUBPOPULATIONOF ARTICULAR CHONDROCYTES
PHENOTYPE AS WELL AS CALCIFIED CARTILAGE AND
SUBCHONDRAL BONE
P. Chen, K. Henriksen, S.H. Madsen, B.C. Søndergaard,
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NordicbioSci. A/S, Herlev, Denmark
Purpose: The pathogenesis of osteoarthritis (OA) is a chronic
process, which include cartilage loss and abnormal differentiation
of chondrocytes. The objective of this study was to develop and
validate a novel ex vivo model for OA, which includes different
chondrocyte phenotypes, as well as the cells of the calciﬁed
cartilage and the subchondral bone. We propose to use this
model to investigate whole tissue pathobiology including cartilage
turnover, cellular interactions between different subpopulations of
chondrycytes, osteoblast and osteoclast upon stimulation with
catabolic and anabolic factors (e.g. proinﬂammatory cytokines and
potentially drug candidates).
Methods: Explant cultures Full depth cartilage explants were
isolated from bovine femoral condyle or tibia plateau and cul-
tured with or without anabolic or catabolic factors; without factors
(W/O), with either Oncostatin M [10ng/ml] combined with TNF-α
[20ng/ml] (O+T), or with IGF-1 [100ng/ml]. The cultures were kept
for 21 days, with medium change three times a week. The super-
natants were collected and stored at -20[[Unsupported Character
- &#8304;]]C until analysis in different assay.
ELISA 342-G2 and 374-G2 aggrecan biomarker assays were used
to test the aggrecan degradation. Moreover, markers of type I and
type II collagens were measured, including: CTX-I, PINP, CTX-II,
PIINP and several new markers of type II collagen.
Histology Safranin O and Fast Green staining were used to visu-
alize the morphology of the explants and evaluate potential signs
of OA-like pathological features. Collagen type X was used for the
biomarker of chondrocyte hypertrophy in full depth cartilage by
Immunohistochemstry.
Results: The alamarblue results showed that both W/O, O+T and
IGF-1 stimulated groups had good viability throughout the whole
culture period (21 days). Hydroxyproline release to the supernatant
from day 21 showed no differences between catabolic and anabolic
treatment. In contrast, the O+T group had more CTX-II fragment
released than the IGF-I group. Aggrecan fragment peak release
was at day 7 of 374-G2 (aggrecanase-mediated) and day 12 of
342-G2 (MMP -mediated), respectively. Type II collagen formation
(PIINP) was signiﬁcantly increased in response to IGF-1, whereas
PINP was not. The new degradation markers of type II collagen
were all released at late stages of the culture period. These
data was supported by histological assessment; GAG staining
was lost after 21 days of culturing with proinﬂammatory cytokines.
Furthermore the presence of type X collagen was more marked in
these catabolic stimulated explants.
Conclusions: We have developed an explant culture models that
include different subpopulations of chondrocytes as well as cal-
ciﬁed cartilage and subchondral bone. Here we have presented
the initial characterization of the model and shown that we can
stimulate the explants to a catabolic or anabolic phenotype. We
speculate that this characterized model could be used for investi-
gation of the effect of different compounds, as well as investigation
of cell-cell interaction between the cartilage and bone compart-
ment.
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Purpose: This study was undertaken to examine the expres-
sion of FoxO transcription factors in human osteoarthritic articular
chondrocytes. Cellular localisation of these transcription factors
is regulated by de PI3K/AKT signaling pathway. Activated AKT
phosphorylated FoxO family members, which induces exclusion of
FoxO from the nucleus. Unphosphorylated FoxO proteins remain
actives in the nucleus and promote the transcription of genes that
regulate proliferation, apoptosis and stress resistance.
Methods: Human osteoarthritic articular chondrocytes were used
in this sudy. Interleukin-1B was used to stimulate chondrocytes
for 1 hour or 24 hours. The expression of FoxO family members
was assessed by western blotting. FoxO1, FoxO3a and FoxO4
localisation was performed by confocal microscopy and immuno-
histochemistry.
Results: Each of the 3 family members, FoxO1, FoxO3a, and
FoxO4, are expressed in human chondrocytes. FoxO3a expression
was found to be more important than FoxO1, whereas FoxO4
expression was very weak. In control cells, all three proteins were
found principaly in the nucleus of the cell ; with some proteins
found in the cytoplasm. Interleukin-1B effects on FoxO familly
members localisation were observed after 24 hours of stimulation,
whereas no obvious changes were observed after 1 hour. IL-1B
treatment for 24 hours induces a cytoplasmic localisation of the
FoxO transcription factors.
Conclusions: This study presents evidence that each of the 3
family members, FoxO1, FoxO3a, and FoxO4, are expressed in
osteoarthritic chondrocytes.
Results show that inﬂammatory extracellular stimulus, such as
IL-1B, was able to promote FoxO phosphorylation in human os-
teoarthritic chondrocytes in vitro. This phosphorylation induces
export of the FoxO proteins from the nucleus to the cytoplasm.
These transcription factors could participate in the regulation of
different phenomena found in the osteoarthritis pathology, like
apoptosis, chondrocyte proliferation, cell dediferentiation or resis-
tance to oxidative stress.
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Purpose: The aim of this study was to investigate the effects of
diacerhein and rhein on FoxO transcription factors on human os-
teoarthritic chondrocytes. These transcription factors are involved
on the control of cell cycle progression, cell proliferation, induc-
tion of apoptosis and protection from oxidative stress ; and are
regulated by the PI3K/AKT transduction pathway.
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Methods: Human osteoarthritic chondrocytes were culture with or
without Interleukin-1B in the presence or absence of Diacerhein
or Rhein for 24 hours. Nitric oxide was estimated via Nitrite quan-
tiﬁcation by the Griess reagent and apoptosis was investigated by
using the Vibrant Apoptosis kit (Molecular Probes). The localisa-
tion of FoxO1, FoxO3a, FoxO4 and protein p65 (a member of the
nuclear factor-kappaB family) was investigated by ﬂuorescence
confocal microscopy. FoxO1, FoxO3a and FoxO4 expression was
determinated by Western blotting.
Results: Diacerhein and Rhein reduced IL-1B - induced NO in-
crease and p65 nuclear localisation as previously shown. In control
cells, FoxO transcription factors were localisated in the cytoplasm.
In the presence of Diacerhein or Rhein, FoxO transcription factors
were found to have nuclear localisation whereas they are in the
cytoplasm in the presence of IL-1B. When Diacerhein or Rhein
are added to the culture medium containing IL-1B, the localisation
of FoxO transcription factors changes and become nuclear. No
signiﬁcant changes were observed on FoxO proteins expression
among the samples of the study.
Conclusions: Previous studies have shown that Diacerein and
its active metabolite reduce the IL-1β deleterious effects on os-
teoarthritis (OA) cartilage through inhibition of the expression of
degrading enzymes. This study presents evidence of the involve-
ment of FoxO transcription factors on diacerein mode of action.
It could explain the downregulated proliferation and the increased
p27 expression observed on human osteoarthritic chondrocytes in
the presence of Rhein recently found by other groups.
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Purpose: Articular chondrocytes are exposed in vivo to the con-
tinually changing osmotic environment and thus require volume
regulatory mechanisms. The present study was designed to in-
vestigate i) the functional role of the swelling-activated Cl- current
(ICl,swell) in the regulatory volume decrease (RVD) and ii) the regu-
latory role of tyrosine phosphorylation in ICl,swell, in isolated rabbit
articular chondrocytes.
Methods: Rabbit cartilages were collected from bilateral knee, hip
and glenohumeral joints of male animals weighing 2.0 to 3.0 kg.
The cartilage was dissected into slices and cultured in DMEM
for 1-3 days. On the day of experiments, chondrocytes were
isolated by enzymatic digestion. Whole-cell membrane current
was recorded during exposure to isosmotic (300 mOsm) and
hyposmotic (210 mOsm) external solutions under conditions where
Na+, K+ and Ca2+ currents were minimized. To measure of cell
volume, isolated chondrocytes were allowed to settle onto the
experimental chamber mounted on an inverted microscope. The
chamber was continuously perfused with bathing solutions at the
rate of 2-3 ml min-1. Microscope images of chondrocytes were
recorded with a CCD digital camera equipped with DS-L2 control
unit at 2560×1592 resolution every 1 min, and the area of the cell
image was measured using Image-J public domain software.
Results: The isolated chondrocytes exhibited a RVD during sus-
tained exposure to hyposmotic solution, which was mostly in-
hibited by the ICl,swell blocker DCPIB (4-(2-butyl-6,7-dichloro-2-
cyclopentyl-indan-1-on-5-yl) oxobutyric acid) at 20 μM. Exposure
to a hyposmotic solution activated ICl,swell, which was also largely
inhibited by 20 μM DCPIB. Activation of ICl,swell was signiﬁcantly
reduced by the protein tyrosine kinase (PTK) inhibitor genistein (30
μM) but was scarcely affected by its inactive analogue daidzein
(30 μM). Intracellular application of protein tyrosine phosphatase
(PTP) inhibitor sodium orthovanadate (250 and 500 μM) resulted
in a gradual activation of a Cl- current even in isosmotic solu-
tions. This Cl- current was almost completely inhibited by DIDS
(4,4’-diisothiocyanatostilbene-2,2’-disulphonic acid, 500 μM) and
was also largely suppressed by exposure to hyperosmotic solu-
tion, thus indicating a close similarity to ICl,swell. Pretreatment of
chondrocytes with genistein signiﬁcantly prevented the activation
of the Cl- current by sodium orthovanadate, suggesting that the
basal activity of endogenous PTK is required for the activation of
this Cl- current.
Conclusions: Our results provide evidence to indicate that acti-
vation of ICl,swell is involved in RVD and is facilitated by tyrosine
phosphorylation in isolated rabbit chondrocytes.
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Objectives: To study the effects of Quantum Magnetic Resonance
(QMR) beams on clinical and functional parameters and cartilage
thickness of osteoarthritic knee joints.
Background of QMR Therapy: Quantum Magnetic Resonance
Therapy™ utilizes highly complex quantum electromagnetic beams
in the sub-radio and near-radio frequency spectrum. The beams
can be precisely controlled and focused onto tissues therein
generating streaming voltage potentials. In osteoarthritis, this ﬂow
in the joint causes forced movement of hydrogen protons in the
extra cellular matrix (ECM) due to the alteration in QMR spin in
the hydrogen atoms and stimulates the chondrocytes.
Methods: After the publication (2004) of the results of a pilot
study on the effect of QMR on 35 patients with osteoarthritis,
300 more patients with osteoarthritis have been treated with QMR
as a follow up study. The patients were assessed on the basis
of well-established internationally recognized knee society rating
system and scores prior to immediately after treatment and further
after three months were computed. In addition, MRI of the knees
was done using standard protocol before and after three months
of treatment with a view to measure the changes in the cartilage
thickness in the knee joints.
Results: By the end of the treatment the patients could walk up
to ﬁve times more than before treatment without any difﬁculty. MRI
showed a remarkable increase in the thickness of the cartilage in
the knee joint at three months, from 0.67mm (±0.02) pre-treatment
to 3.25mm (±0.74) in left knee, and 0.66mm (±0.02) to 2.71mm
(±0.58) in the right knee joint (p<0.001).
Conclusions: QMR Therapy™ has now been successfully em-
ployed to induce mitotic activity in the fully differentiated chon-
drocytes. It is also seen that therapeutic exposure to quantum
magnetic resonance beams is effective in ameliorating the signs
and symptoms of OA, and inducing regenerative activity in the
chondrocytes as evidenced by an increase in the cartilage thick-
ness. QMR Therapy™ is a method for regeneration of cartilage
and is effective for treatment of osteoarthritis of the knee joint.
